Showing results (1451-1460 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|April 19, 2021
License to kill: microsatellite instability and immune contexturePauline Maby, Gabriela Bindea, Bernhard Mlecnik, et al.Oncoimmunology|April 19, 2021
CD80 expression is upregulated by TP53 activation in human cancer epithelial cellsMelania Scarpa, Chiara Marchiori, Marco Scarpa, et al.Oncoimmunology|April 19, 2021
Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing DataYi-Quan Jiang, Zi-Xian Wang, Ming Zhong, et al.Oncoimmunology|April 15, 2021
Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancerCong Chen, Yan-Mei Gu, Fan Zhang, et al.Oncoimmunology|November 7, 2022
Bispecific T cell engagers kill resistant cells during KRAS-G12C blockade therapyXinxin Song, Zhuan Zhou, Rui Kang, et al.Oncoimmunology|November 7, 2022
Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosisAlfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, et al.Oncoimmunology|October 3, 2022
Immunotherapy approaches for the treatment of diffuse midline gliomasJoshua D Bernstock, Samantha E Hoffman, Ari D Kappel, et al.Oncoimmunology|October 3, 2022
Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivoErnesto Gargiulo, Elodie Viry, Etienne Moussay, et al.Oncoimmunology|January 18, 2024
Platelet-derived microparticles adoptively transfer integrin β3 to promote antitumor effect of tumor-infiltrating T cellsMimi Zhou, Yali Feng, Xiaoli Zhang, et al.Oncoimmunology|January 18, 2024
Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapyYing Zheng, Andriana Lebid, Liam Chung, et al.Pageof 380